Christophe Bonny

7.6k total citations · 2 hit papers
114 papers, 6.3k citations indexed

About

Christophe Bonny is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Christophe Bonny has authored 114 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 30 papers in Surgery and 25 papers in Genetics. Recurrent topics in Christophe Bonny's work include Pancreatic function and diabetes (22 papers), Metabolism, Diabetes, and Cancer (16 papers) and Cell death mechanisms and regulation (12 papers). Christophe Bonny is often cited by papers focused on Pancreatic function and diabetes (22 papers), Metabolism, Diabetes, and Cancer (16 papers) and Cell death mechanisms and regulation (12 papers). Christophe Bonny collaborates with scholars based in Switzerland, France and United States. Christophe Bonny's co-authors include Gérard Waeber, Daniel F. Schorderet, Pascal Nicod, Tiziana Borsello, Anne Oberson, Lorenz Hirt, Alessandro Vercelli, Mariaelena Repici, Robert Clarke and Nancy A. Thompson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Christophe Bonny

111 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia

2003 580 citations Tiziana Borsello, Lorenz Hirt et al. profile →
Cell-Permeable Peptide Inhibitors of JNK

2001 514 citations Christophe Bonny, Daniel F. Schorderet et al. profile →

Peers

Countries citing papers authored by Christophe Bonny

Since Specialization

Citations

This map shows the geographic impact of Christophe Bonny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Bonny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Bonny more than expected).

Fields of papers citing papers by Christophe Bonny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Bonny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Bonny. The network helps show where Christophe Bonny may publish in the future.

Co-authorship network of co-authors of Christophe Bonny

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Bonny. A scholar is included among the top collaborators of Christophe Bonny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Bonny. Christophe Bonny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of a muropeptide precursor transporter from gut microbiota and its role in preventing intestinal inflammation 2023 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), (unknown), João G. Magalhães, (unknown), Francesco Strozzi, (unknown), Marc Maresca, Cendrine Nicoletti, Eric Di Pasquale, (unknown), (unknown), Stephen E. Girardin, Ivo G. Boneca, Joël Doré, Hervé M. Blottière, Christophe Bonny, Laurent Chêne, Antonietta Cultrone	7
2	Low-dose IL-2 shapes a tolerogenic gut microbiota that improves autoimmunity and gut inflammation 2022 ·JCI Insight ·Nicolas Tchitchek, (unknown), (unknown), (unknown), Julien Campagne, Guillaume Churlaud, Gwladys Fourcade, Thomas Hoffmann, Francesco Strozzi, (unknown), Christophe Bonny, Emmanuelle Le Chatelier, (unknown), Harry Sokol, David Klatzmann	14
3	Regulation of the JNK3 Signaling Pathway during Islet Isolation: JNK3 and c-fos as New Markers of Islet Quality for Transplantation 2014 ·PLoS ONE ·Saida Abdelli, Klearchos K. Papas, Kate R. Mueller, (unknown), Bernhard J. Hering, Christophe Bonny	7
4	Role of JNK Isoforms in the Development of Neuropathic Pain following Sciatic Nerve Transection in the Mouse 2012 ·Molecular Pain ·(unknown), (unknown), Stefano Cobianchi, Valeria Valsecchi, Christophe Bonny, Ferdinando Rossi, Alessandro Vercelli	32
5	c‐Jun N‐terminal kinase signaling pathway in excitotoxic cell death following kainic acid‐induced status epilepticus 2010 ·European Journal of Neuroscience ·Giada Spigolon, (unknown), Christophe Bonny, Alessandro Vercelli	58
6	The c-Jun N-terminal kinase (JNK) inhibitor XG-102 enhances the neuroprotection of hyperbaric oxygen after cerebral ischaemia in adult rats 2009 ·Neuropathology and Applied Neurobiology ·(unknown), Yi Zhao, Andreas Patzer, (unknown), (unknown), Günther Deuschl, Juraj Čulman, Christophe Bonny, Thomas Herdegen, Christoph Eschenfelder	29
7	841 EFFICACY AND SAFETY OF 2 YEARS MAINTENANCE THERAPY WITH PEGINTERFERON ALPHA-2A IN CHRONIC HEPATITIS C: RESULTS OF A RANDOMIZED CONTROLLED TRIAL (FIBROSYS) 2008 ·Journal of Hepatology ·Jean‐Pierre Zarski, Nathalie Stürm, Hervé Desmorat, P. Mélin, Jean–Jacques Raabe, Christophe Bonny, (unknown), (unknown), Stéphanie Rouanet, (unknown), Marie Chevallier	1
8	The JNK Inhibitor XG-102 Protects from Ischemic Damage with Delayed Intravenous Administration Also in the Presence of Recombinant Tissue Plasminogen Activator 2008 ·Cerebrovascular Diseases ·(unknown), Christophe Bonny, (unknown), Lorenz Hirt	48
9	Novel Strategy for Treatment of Viral Central Nervous System Infection by Using a Cell-Permeating Inhibitor of c-Jun N-Terminal Kinase 2007 ·Journal of Virology ·J. David Beckham, Robin J Goody, Penny Clarke, Christophe Bonny, Kenneth L. Tyler	36
10	Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation 2007 ·Neuroscience ·Mariaelena Repici, Catherine Centeno, Simone Tomasi, Gianluigi Forloni, Christophe Bonny, Alessandro Vercelli, Tiziana Borsello	74
11	The epidemiology and virology of hepatitis C virus genotype 5 in central France 2007 ·Alimentary Pharmacology & Therapeutics ·Armand Abergel, Sylvie Ughetto, (unknown), Christophe Bonny, Bruno Aublet‐Cuvelier, Elisabeth Delarocque‐Astagneau, Jean‐Luc Bailly, Gilles Bommelaer, S. Casanova, (unknown), Paul Dény, H. Laurichesse, (unknown), (unknown), H. Peigue‐Lafeuille, Cécile Henquell	13
12	Blocking Stress Signaling Pathways with Cell Permeable Peptides 2006 ·Advances in experimental medicine and biology ·Christophe Bonny	2
13	Homogeneous and Nonradioactive High-Throughput Screening Platform for the Characterization of Kinase Inhibitors in Cell Lysates 2006 ·SLAS DISCOVERY ·(unknown), Nathalie Rouleau, (unknown), (unknown), Fabienne Maurer, Nathalie Allaman-Pillet, Pascal Nicod, (unknown), J. Beckmann, Christophe Bonny, Roger Bossé, Raphaël Roduit	19
14	Targeted Silencing of RPE65 in the Retinal Pigment Epithelial Cell Line ARPE–19 Using Lentivirus–Mediated siRNA Delivery 2005 ·Investigative Ophthalmology & Visual Science ·Sandra Cottet, Tatiana Favez, Francisca Maurer, Christophe Bonny, Yvan Arsenijévic, Francis L. Munier, Daniel F. Schorderet	1
15	D‐TAT transporter as an ocular peptide delivery system 2005 ·Clinical and Experimental Ophthalmology ·Daniel F. Schorderet, (unknown), (unknown), Christophe Bonny, Yvan Arsenijévic, Francis L. Munier, Fabienne Maurer	27
16	Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: 2005 ·Liver International ·Richard Moreau, Dominique Valla, Isabelle Durand‐Zaleski, Jean–Pierre Bronowicki, François Durand, Jean‐Claude Chaput, Innocenti Dadamessi, Christine Silvain, Christophe Bonny, Frédéric Oberti, Jérôme Gournay, Didier Lebrec, Jean‐Marie Grouin, (unknown), (unknown), (unknown), Z. Tellier	69
17	Antitumorigenic Effect of Proteasome Inhibitors on Insulinoma Cells 2004 ·Endocrinology ·Joachim Størling, Nathalie Allaman-Pillet, Allan E. Karlsen, Nils Billestrup, Christophe Bonny, Thomas Mandrup‐Poulsen	12
18	Mutated BIGH3 induces apoptosis in Human Corneal and HeLa cells through an integrin recognition site 2002 ·Investigative Ophthalmology & Visual Science ·(unknown), Sabine Morand, (unknown), Francisca Maurer, Yvan Arsenijévic, Christophe Bonny, (unknown)	1
19	Genomic Characterization and Embryonic Expression of the Mouse Bigh3 (Tgfbi) Gene 2000 ·Biochemical and Biophysical Research Communications ·Daniel F. Schorderet, M Ménasche, Sabine Morand, Sébastien Bonnel, (unknown), Dominique Marchant, (unknown), Christophe Bonny, Marc Abitbol, Francis L. Munier	51
20	Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. 1996 ·Molecular Endocrinology ·Gérard Waeber, Nancy A. Thompson, Pascal Nicod, Christophe Bonny	282

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact